ibudilast has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with ibudilast was generally safe and well tolerated." | 2.75 | Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? ( Barkhof, F; Drulovic, J; Hulst, HE; Landin, R; Matsuda, K; Uitdehaag, BM, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkhof, F | 1 |
| Hulst, HE | 1 |
| Drulovic, J | 1 |
| Uitdehaag, BM | 1 |
| Matsuda, K | 1 |
| Landin, R | 1 |
| Feng, J | 1 |
| Misu, T | 1 |
| Fujihara, K | 1 |
| Sakoda, S | 1 |
| Nakatsuji, Y | 1 |
| Fukaura, H | 1 |
| Kikuchi, S | 1 |
| Tashiro, K | 1 |
| Suzumura, A | 1 |
| Ishii, N | 1 |
| Sugamura, K | 1 |
| Nakashima, I | 1 |
| Itoyama, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center, Open-Label Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)[NCT02714036] | Phase 1/Phase 2 | 35 participants (Actual) | Interventional | 2016-05-06 | Completed | ||
| Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471] | Phase 3 | 400 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ibudilast and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Topics: Adult; Brain; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Magne | 2010 |
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Topics: Adult; Brain; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Magne | 2010 |
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Topics: Adult; Brain; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Magne | 2010 |
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Topics: Adult; Brain; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Magne | 2010 |
Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis.
Topics: Adult; Female; Flow Cytometry; Humans; Killer Cells, Natural; Lymphocytes; Male; Multiple Sclerosis, | 2004 |